A pipeline for testing drug mechanism of action and combination therapies: from microarray data to simulations via linear-in-flux-expressions. Testing four-drug combinations for tuberculosis treatment
DOI10.1016/J.MBS.2023.108983zbMATH Open1519.92096OpenAlexW4324365189MaRDI QIDQ6133977FDOQ6133977
Nathaniel J. Merrill, Christopher Denaro, Logan Reed, B. Piccoli, Karim Azer, Sean T. McQuade
Publication date: 25 July 2023
Published in: Mathematical Biosciences (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.mbs.2023.108983
Recommendations
- Metabolic graphs, the LIFE method, and modeling drug action on \textit{Mycobacterium tuberculosis}
- Mathematical modeling of pulmonary tuberculosis therapy: insights from a prototype model with rifampin
- Mathematical modeling and systems pharmacology of tuberculosis: isoniazid as a case study
- A computational tool integrating host immunity with antibiotic dynamics to study tuberculosis treatment
- MATHEMATICAL MODELING OF CHEMOTHERAPY OF HUMAN TB INFECTION
Medical applications (general) (92C50) Systems biology, networks (92C42) Computational methods for problems pertaining to biology (92-08)
Cites Work
This page was built for publication: A pipeline for testing drug mechanism of action and combination therapies: from microarray data to simulations via linear-in-flux-expressions. Testing four-drug combinations for tuberculosis treatment
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6133977)